LOINC Code 95556-7: Adrenal cancer risk assessment and urine steroid fractions panel

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Adrenal cancer risk assessment & urine steroid fractions panel. It is commonly used with the system or sample type ^Patient.

When is it used?

• Used in lab systems, EHRs, and clinical data exchange.
• May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
• Status: ACTIVE
• Order vs observation: Order
• Panel type: Panel

What it does not mean

• The code identifies the observation or test, not the actual result.

Key facts

• Adrenal cancer risk assessment and urine steroid fractions panel
• Adrenal cancer risk assessment & urine steroid fractions panel
• A risk assessment based on patient clinical data combined with biochemical steroid results to assess the probability of a malignant adrenal cortical carcinoma (ACC) or other malignancy (e.g. sarcoma, lymphoma) versus the probability of a benign mass (e.g. adenoma, myelolipoma, cyst). Clinical biomarkers may include age at diagnosis, gender, mode of discovery, hormonal status (e.g. overproduction), tumor diameter, and density of the tumor by CT.
• Adrenal ca risk assess+ur steroid Pnl; Adrnl; CAH; Chemistry; Congenital adrenal hyperplasia; Frac; Fract; Fraction; Fractionated; Fractionation; Pan; PANEL.CHEMISTRY; Panl; Pnl; Steroid Fract Pnl

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

Frequently asked questions